ASCO GU 2020: Randomised clinical trial of HIF-2α inhibitor in patients with advanced kidney cancer
A randomised clinical trial of hypoxia inducible factor 2α (HIF-2α) [...]
A randomised clinical trial of hypoxia inducible factor 2α (HIF-2α) [...]
In this video interview, Dr Eric Jonasch from MD Anderson [...]
Results from the first in human study of the HIF-2α [...]
A recent phase I/II clinical trial with PT2977, a hypoxia-inducible [...]
Researchers in America are looking at a new class of [...]
The results of a first-in-human phase I clinical trial with [...]